Clinical Trial Update: A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating selinexor in combination with carfilzomib, daratumumab, or pomalidomide in patients with multiple myeloma; the trial status is suspende…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (Kyprolis) (carfilzomib)
• Daratumumab (Darzalex) (daratumumab)
• Pomalidomide (Pomalyst) (pomalidomide)
• Selinexor (Xpovio) (Selinexor)

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Multiple Myeloma | Phase 2 | Status: SUSPENDED